Thioctic Acid for Hair Regrowth - Quick Reference Sheet
evipedia.ai
← Back

Thioctic Acid for Hair Regrowth

Created on 10/11/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Thioctic acid, an inexpensive antioxidant dietary supplement, is proposed to protect hair roots from damage by unstable oxygen molecules. Taken orally, it has never been tested on hair growth in people; a scalp lotion made from a modified form did not stop hair loss during cancer treatment. Its risks are uncommon but real, chiefly kidney inflammation and low blood sugar, which routine urine and blood-sugar tests can detect early. (Full Review)

Protocol

Oral standard dose
600 mg once daily
Racemic thioctic acid (equal mix of R- and S-forms); no hair-specific dose exists
Time of day
Empty stomach
30–60 minutes before a meal, because food reduces bioavailability; morning dosing is common
Topical regimen
1% derivative lotion
Daily during chemotherapy, or twice daily from 6 days before to 90 days after chemotherapy plus scalp cooling
Time to effect
Modest weight reduction
10–20 weeks
Small weight losses in randomized placebo-controlled trials of this length
Fewer migraine attacks
12 weeks
Lower attack frequency and severity versus placebo
Visible hair change
3–6 months
Set by hair growth phases; derivative studies assessed recovery at 90 days

Benefits

Contraindications
  • Prior insulin autoimmune syndrome or known HLA-DRB1*04:06 or *04:03 carriage
  • Existing protein in the urine or a history of membranous nephropathy
  • Chemotherapy or radiotherapy (oral use without oncology-team agreement; theoretical)
    •
Key Interactions
  • Glucose-lowering drugs (insulin, sulfonylureas such as glibenclamide, acarbose): monitor
  • Glucose-lowering supplements (berberine, chromium, cinnamon, myo-inositol): monitor (theoretical)
  • Thiol drugs (methimazole, carbimazole, captopril, penicillamine): caution (theoretical)
  • Other thiol supplements (N-acetylcysteine, glutathione): caution (theoretical)
  • Thyroid hormone (levothyroxine): monitor (theoretical)
  • Non-steroidal anti-inflammatory drugs (ibuprofen, naproxen): caution (theoretical)
  • Antacids and mineral products (iron, zinc, magnesium): minor (theoretical); separate by two hours
  • Biotin: complementary (theoretical)
    •

Risk & Side Effects

  • High:
  • Medium: Membranous nephropathy and protein in the urine
    •
  • Low: Insulin autoimmune syndrome; digestive upset; headache; skin reactions; excess serious adverse events in long-term use; severe toxicity in overdose; liver injury; allergic contact dermatitis from topical products; adverse events with the topical derivative lotion
    •
  • Speculative: Competition with biotin; blunting of chemotherapy or radiotherapy; reduced thyroid hormone activation; harm in thiamine deficiency
    •

Monitoring

Marker Target Why
Urine protein (dipstick) Negative Safety check: new protein stops use
Serum creatinine 0.6–1.3 mg/dL Safety check: kidney function
Fasting glucose 70–99 mg/dL Safety check: low blood sugar from insulin antibodies
TSH (thyroid hormone users only) 0.4–4.0 mIU/L Safety check: hormone activation
Hair-shaft diameter (trichoscopy) No established target; change from own baseline Expected to change with use

Cadence: Baseline, at 3 months after starting, then every 6 months (urine protein and creatinine); TSH 6–8 weeks after starting in levothyroxine users; fasting glucose at once if shaky or sweaty episodes occur; photographs and hair-shaft measurements at 3, 6 and 12 months

Qualitative Assessment

  • Shedding volume (hairs lost per wash or brushing)
  • Hair density and part width on standardized photographs
  • Hair texture and breakage
  • Digestive tolerance (nausea, reflux)
  • Skin reactions (itching, hives)
  • Shakiness, sweating or confusion suggesting low blood sugar
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.